Accurate, robust and simple method of identification has potential benefits to patients, hospitals and health services around the world.
A Clostridium difficile (C. diff) infection is one that can affect the digestive system and most commonly affects people staying in hospital.
It is not generally a problem for healthy people but may infect those on antibiotics with an imbalance of ‘good bacteria’ in the gut.
A research paper published today, 2nd August 2013, in BMC Infectious Diseases has for the first time identified a unique four-point test using easily measurable clinical variables which can be used to accurately predict the death risk to patients from C. diff. Accurate prediction means that those patients at risk can be managed accordingly by the clinical team.